BMRN vs PAMT · P/E 40, rev $1.76B vs rev $306.5M
Biomarin Pharmaceutical Inc (BMRN) versus PAMT CORP (PAMT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
PAMT CORP (PAMT) is a trucking company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PAMT revenue for 2026-06-30 was $306.5M. Net income was -$7.5M. PAMT currently screens at market cap $302.9M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PAMT currently screens at market cap $302.9M.
Not investment advice. Open the BMRN and PAMT stock pages for the full models.
Not investment advice.